New Techniques for Age-Related Macular Degeneration

Scientists at UC Santa Barbara, University of Southern California (USC), and the biotechnology company Regenerative Patch Technologies LLC (RPT) have discovered a new method for preserving RPT's stem cell-based therapy for age-related macular degeneration (AMD), the leading cause of blindness in aging populations. This new research uses a flexible scaffold, about 18 mm2, to optimize the cryopreservation of a single layer of ocular cells generated from human embryonic stem cells. Currently in clinical trials, this implant can be frozen, stored for long periods, distributed to clinical sites, then thawed and immediately implanted into the patient's eyes. The extended shelf-life and on-demand distribution will increase the number of patients who can benefit from this treatment. Read the full article. 

 

Share this post:

Comments on "New Techniques for Age-Related Macular Degeneration"

Comments 0-5 of 0

Please login to comment